Document Detail


Birth defects in relation to Bendectin use in pregnancy. II. Pyloric stenosis.
MedLine Citation:
PMID:  6650593     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To test the hypothesis that the use of Bendectin in pregnancy increases the risk of pyloric stenosis, we determined rates of antenatal Bendectin exposure among 325 infants with pyloric stenosis and among two control groups comprising infants with other defects; one consisted of 3,153 infants with other conditions, and the other, a subset of that group, consisted of 724 infants with defects that may have had their origins at any time in pregnancy. Comparisons between the cases and the two control series yielded estimated relative risks of 0.9 (95% confidence interval, 0.6 to 1.2) and 1.0 (0.7 to 1.4), respectively. The findings from this large case-control study suggest that Bendectin does not increase the risk of pyloric stenosis.
Authors:
A A Mitchell; P J Schwingl; L Rosenberg; C Louik; S Shapiro
Related Documents :
16906563 - Risk of limb deficiency defects associated with nat1, nat2, gstt1, gstm1, and nos3 gene...
17988253 - Congenital malformations in infants whose mothers reported the use of folic acid in ear...
15159113 - Rate of abnormalities in lambs from in vitro produced embryos transferred on day 2 comp...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  147     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1983 Dec 
Date Detail:
Created Date:  1984-01-07     Completed Date:  1984-01-07     Revised Date:  2010-07-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  737-42     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology*
Doxylamine / adverse effects*
Drug Combinations / adverse effects
Female
Humans
Hyperemesis Gravidarum / drug therapy
Infant
Male
Maternal-Fetal Exchange
Pregnancy
Prenatal Care
Pyloric Stenosis / chemically induced*,  genetics
Pyridines / adverse effects*
Pyridoxine / adverse effects*
Questionnaires
Risk
Sex Factors
Grant Support
ID/Acronym/Agency:
223-76-3016//PHS HHS; 223-80-3001//PHS HHS; 226-82-0007//PHS HHS
Chemical
Reg. No./Substance:
0/Drug Combinations; 0/Pyridines; 0/dicyclomine, doxylamine, pyridoxine drug combination; 469-21-6/Doxylamine; 65-23-6/Pyridoxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Renal functional recovery 47 days after renal artery occlusion.
Next Document:  Clinical experience with one hundred seven diabetic pregnancies.